Table 6.
Time to progression (weeks) |
Total # of patients |
Most common tumor types |
Most common dose levels |
Reasons to be off protocol other than PD (AE/Noncompliance) |
---|---|---|---|---|
9 | 5 | Melanoma/liposarcoma | 5 and 11 | 2/2 |
12 | 9 | Melanoma/ appendiceal cancer/ head and neck cancer/ NSCLC/ RCC | 2A and 1 | 3/3 |
15 | 3 | Melanoma/ head and neckcancer/ appendiceal cancer | 4,7,1A | 2/0 |
18 | 3 | Melanoma/ small cell lung cancer | 3,10, 2A | 0/1 |
22 | 1 | Melanoma | 2A | 0/0 |